Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).

Autor:	Martinez Chanza, Nieves1,2 (AUTHOR) Nieves.Martinez-Chanza@bordet.be, Soukane, Louisa2 (AUTHOR), Barthelemy, Philippe3 (AUTHOR), Carnot, Aurélien4 (AUTHOR), Gil, Thierry1 (AUTHOR), Casert, Vinciane5 (AUTHOR), Vanhaudenarde, Vincent6 (AUTHOR), Sautois, Brieuc7 (AUTHOR), Staudacher, Lionel8 (AUTHOR), Van den Brande, Jan9 (AUTHOR), Culine, Stephane10 (AUTHOR), Seront, Emmanuel11 (AUTHOR), Gizzi, Marco12 (AUTHOR), Albisinni, Simone2 (AUTHOR), Tricard, Thibault3 (AUTHOR), Fantoni, Jean Christophe4 (AUTHOR), Paesmans, Marianne1 (AUTHOR), Caparica, Rafael1 (AUTHOR), Roumeguere, Thierry1,2 (AUTHOR), Awada, Ahmad1 (AUTHOR)
Zdroj:	BMC Cancer. 12/2/2021, Vol. 21 Issue 1, p1-8. 8p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu